John Supan

John Supan

John Supan joined FLG in 2005 and served on the firm’s Management Committee from 2013-2016. John has over 30 years of business experience working with both public and private companies. His primary interest and experience is with emerging growth high technology and life sciences companies, including medical device, instruments, software, data and specialty pharma.   Prior to FLG, John worked with a multitude of companies both as an Audit Partner and advisor while at Ernst & Young and as the CFO.

John’s experience spans strategic, financial and business planning, IPOs, equity and debt financings, and merger and acquisition analysis, execution and integration, both domestically and internationally.

Prior to joining FLG Partners, John was the CFO for a web-based software and data company providing clinical trial services to pharmaceutical and biotech companies. As CFO of Argonaut Technologies, John was recruited to file the Company’s S-1 registration statement and to represent the Company during the IPO road show. He also served as the CFO of Beacon Diagnostics, a medical diagnostics company. He is a Certified Public Accountant and spent 15 years with Ernst & Young LLP. He began his career at Alza Corporation, a publicly traded drug delivery systems company. John’s first assignment with FLG Partners involved a three-year residency in Hong Kong where he served as the CFO for Peak International Limited (NASDAQ: PEAK), a precision plastics injection molding company serving the high technology industry.

John holds a BS degree in Business Administration (Accounting) from California State University, San Jose, and is a Certified Public Accountant in CA (inactive). In June 2005, John attended the Stanford University School of Law, Directors’ College.